Clearside Biomedical Inc (NASDAQ: CLSD) is -4.27% lower on its value in year-to-date trading and has touched a low of $0.65 and a high of $2.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLSD stock was last observed hovering at around $1.11 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $1.12, the stock is -11.93% and -3.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.77 million and changing 0.90% at the moment leaves the stock -12.98% off its SMA200. CLSD registered 25.18% gain for a year compared to 6-month gain of -11.11%. The firm has a 50-day simple moving average (SMA 50) of $1.15514 and a 200-day simple moving average (SMA200) of $1.287235.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.18% loss in the last 1 month and extending the period to 3 months gives it a -2.61%, and is -14.50% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.79% over the week and 11.26% over the month.
Clearside Biomedical Inc (CLSD) has around 30 employees, a market worth around $83.72M and $7.52M in sales. Profit margin for the company is -444.66%. Distance from 52-week low is 72.28% and -47.17% from its 52-week high. The company has generated returns on investments over the last 12 months (-176.65%).
The EPS is expected to grow by 6.74% this year
58.0 institutions hold shares in Clearside Biomedical Inc (CLSD), with institutional investors hold 28.43% of the company’s shares. The shares outstanding are 74.75M, and float is at 63.26M with Short Float at 0.41%. Institutions hold 26.33% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 2.84 million shares valued at $3.69 million. The investor’s holdings represent 4.0656 of the CLSD Shares outstanding. As of 2024-06-30, the second largest holder is ROSALIND ADVISORS, INC. with 2.59 million shares valued at $3.37 million to account for 3.7115 of the shares outstanding. The other top investors are ARMISTICE CAPITAL, LLC which holds 2.14 million shares representing 3.0578 and valued at over $2.78 million, while CARMIGNAC GESTION holds 3.0532 of the shares totaling 2.13 million with a market value of $2.77 million.
Clearside Biomedical Inc (CLSD) Insider Activity
The most recent transaction is an insider purchase by Chong Ngai Hang Victor, the company’s Chief Medical Officer. SEC filings show that Chong Ngai Hang Victor bought 23,500 shares of the company’s common stock on Jun 24 ’24 at a price of $1.06 per share for a total of $24910.0. Following the purchase, the insider now owns 63500.0 shares.
Clearside Biomedical Inc disclosed in a document filed with the SEC on May 15 ’24 that YERXA BENJAMIN R (Director) bought a total of 7,813 shares of the company’s common stock. The trade occurred on May 15 ’24 and was made at $1.31 per share for $10235.0. Following the transaction, the insider now directly holds 17957.0 shares of the CLSD stock.
Still, SEC filings show that on Apr 18 ’24, Gibney Anthony S (Director) acquired 93,290 shares at an average price of $1.30 for $0.12 million. The insider now directly holds 100,000 shares of Clearside Biomedical Inc (CLSD).
